Exelixis (EXEL) Q1 2024 Earnings Call Transcript
EXEL earnings call for the period ending March 31, 2024.
Source: fool.com
Stay updated with breaking news from Jeff Hung. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
EXEL earnings call for the period ending March 31, 2024.
Operator: Good day, and welcome to bluebird bio Fourth Quarter and 2023 Annual Results Conference Call. At this time all participants are in a listen-only mode.
ACADIA Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $0.28 EPS, expectations were $0.32. ACADIA Pharmaceuticals Inc.
Operator: Good morning ladies and gentlemen and welcome to the Amicus Therapeutics' Full Year 2023 Financial Results Conference Call and Webcast.
EXEL earnings call for the period ending December 31, 2023.